RHYTHM PHARMACEUTICALS, INC. (RYTM) Operating income 2016–2025
RHYTHM PHARMACEUTICALS, INC. (RYTM) annual operating income history from SEC filings — each fiscal year as reported.
-$192.0MFY2025 · since FY2016: -$25.9M → -$192.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$192.0M | +27.7% |
| FY2024 | -$265.5M | -44.0% |
| FY2023 | -$184.4M | -2.9% |
| FY2022 | -$179.2M | -5.3% |
| FY2021 | -$170.1M | -24.5% |
| FY2020 | -$136.6M | +6.5% |
| FY2019 | -$146.0M | -86.2% |
| FY2018 | -$78.4M | -141.9% |
| FY2017 | -$32.4M | -25.1% |
| FY2016 | -$25.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RYTM financial trends
RYTM RevenueRYTM Net incomeRYTM Net marginRYTM Gross profitRYTM Gross marginRYTM Operating marginRYTM Operating cash flowRYTM Free cash flowRYTM Capital expendituresRYTM Return on equityRYTM Stock buybacksRYTM Dividends paidRYTM Total assetsRYTM Total liabilitiesRYTM Shareholders’ equityRYTM overview →